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ABSTRACT (
Microbes are talented chemists with the ability to generate tremendously complex and diverse 
natural products which harbor potent biological activities. Natural products are produced using 
sets of specialized biosynthetic enzymes encoded by secondary metabolism pathways. Here, we 
present a two-step evolutionary model to explain the diversification of biosynthetic pathways that 
account for the proliferation of these molecules. We argue that the appearance of natural product 
families has been a slow and infrequent process. The first step led to the original emergence of 
bioactive molecules and different classes of natural products. However, much of the chemical 
diversity observed today has resulted from the endless modification of the ancestral biosynthetic 
pathways. The second step rapidly modulates the pre-existing biological activities to increase their 
potency and to adapt to changing environmental conditions. We highlight the importance of 
enzyme promiscuity in this process, as it facilitates both the incorporation of horizontally 
transferred genes into secondary metabolic pathways and the functional differentiation of proteins 
to catalyze novel chemistry. We provide examples where single point mutations or recombination 
events have been sufficient for new enzymatic activities to emerge. A unique feature in the 
evolution of microbial secondary metabolism is that gene duplication is not essential but offers 
opportunities to synthesize more complex metabolites. Microbial natural products are highly 
important for the pharmaceutical industry due to their unique bioactivities. Therefore, 
understanding the natural mechanisms leading to the formation of diverse metabolic pathways is 
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INTRODUCTION
Microbial natural products are chemically complex metabolites that occupy an unusual chemical 
space [1–3]. A key feature of natural products is that they possess potent biological activities and 
have proven to be a rich source of pharmaceutical agents [1,2]. The potency of these molecules is 
reflected in their widespread use in the treatment of a variety of human diseases [1,2]. A large 
portion of drugs approved for clinical use are based on or inspired by natural products [1]. Fifty-
eight percent of antibiotics and 32% of anticancer agents approved for medical use in the last 35 
years are natural products or their semi-synthetic derivatives [2]. Natural products can target 
biological macromolecules in a highly selective fashion and are widely used as chemical probes 
[4]. In addition, natural products have traditionally been the pinnacle of organic synthesis due to 
their complexity and they have inspired the development of many advanced synthetic methods in 
organic chemistry [5].
The role of natural products in the biology of the producing organisms is not always clear. 
However, many have important and diverse roles in the ecology and physiology of microbes [6,7]. 
Natural products with antimicrobial, antifungal and cytotoxic activities are widely believed to 
facilitate chemical warfare with other organisms [6] or as act as part of a chemical defense [8]. 
These compounds can inhibit key cellular processes such as DNA replication, transcription and 
translation [1,2], but may also act as highly selective and potent enzyme inhibitors or destroy cell 
membranes [4]. However, many secondary metabolites can also serve as iron-scavenging 
siderophores [9], function as natural sunscreens [10] or act as signaling molecules in microbial 
chemical communication [11]. The diverse biological activities are generally thought to improve 
fitness and confer a competitive advantage on the producing microbes [12].
Natural Product Biosynthesis and Comparative Genomics
The majority of microbial natural products share a common biosynthetic logic and can be assigned 
to just a handful of major classes, including terpenes, saccharides, polyketides, alkaloids, and 
peptides [13–16]. Natural products are synthesized through complex secondary metabolic 
pathways consisting of enzymes that can catalyze challenging sequential chemical transformations 
in a regioselective and stereoselective manner [13, 14, 17–19]. Microbial natural product 
biosynthetic pathways are typically organized in self-contained gene clusters that can be over 100 
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enzymes work in coordinated enzyme cascades to produce complex metabolites using a limited 
number of primary metabolites as starting material [12, 15, 21]. The chemical diversity of natural 
products can also be increased through enzymes that supply unusual dedicated precursor substrates 
or catalyze tailoring reactions [12, 20, 22]. Families of natural products that exhibit chemical 
variation typically have a set of conserved biosynthetic enzymes for the synthesis of a core that 
defines the family, but also a set of accessory tailoring enzymes that are not universally conserved 
[12, 17]. The gene clusters typically encode all of the enzymatic reactions needed to assemble a 
natural product using substrates recruited from primary metabolism, but also encode genes for 
regulation, resistance and transport of natural products through coordinated expression of the 
secondary metabolic pathways [12, 20]. 
Many microbes specialize in the production of natural products and have large genomes rich in 
natural product biosynthetic genes [12, 20, 23]. The organization of natural product biosynthetic 
enzymes into regulated gene clusters has facilitated the identification of biosynthetic gene clusters 
and enabled the detection of numerous cryptic pathways encoding novel natural products from 
rapidly accumulating public microbial genome sequence data [20, 23–25]. Many of these 
biosynthetic pathways appear silent and under strict regulation, and the metabolites are produced 
only in response to various environmental stimuli [26, 27]. Natural product biosynthetic gene 
clusters are much more wide-spread and more diverse in nature than anticipated and are frequently 
encountered in microbes not typically associated with natural products [23, 24]. For instance, 
numerous secondary metabolic pathways have been discovered by metagenomics sequencing of 
the uncultured microbes of the human microbiota [28, 29] and a variety of other microbial 
communities [30]. 
Enzyme Promiscuity Drives the Structural Diversification of Natural Products. 
The biosynthesis of numerous chemical variants is a hallmark of secondary metabolism [1, 2]. A 
wealth of data indicates that enzyme promiscuity is an inherent property of natural product 
biosynthetic enzymes [31–35]. Enzyme promiscuity can be divided into substrate promiscuity, 
which describes the ability of the enzyme to utilize a wide range of substrates to catalyze similar 
chemical transformations, and catalytic promiscuity, where the enzyme catalyzes secondary 









This article is protected by copyright. All rights reserved
can be considered key driving forces for the diversification of natural product biosynthetic 
enzymes [37].
Enzymes involved in natural product biosynthesis appear to harbor several important general 
features that promote promiscuity [38]. Natural product biosynthetic enzymes are “generalists”, 
which typically display slow reaction rates and substrate promiscuity [31]. These enzymes have 
been widely shown to harbor weak secondary “moonlighting” activities [32, 39, 40]. This catalytic 
promiscuity promotes the ability to catalyze fortuitous chemical transformations and may form the 
seed for the emergence of new enzymatic activities [41]. Furthermore, natural product biosynthetic 
pathways often encode multi-functional enzymes that catalyze either several consecutive reactions 
with different regiospecificity [42, 43] or entirely different chemical transformations [39, 44]. 
In many ways, proteins involved in secondary metabolism are reminiscent of “generalist” 
primordial enzymes that were responsible for shaping the primary metabolisms of organisms. 
These ancestral proteins responsible for establishing the core primary metabolic pathways, which 
are shared by most organisms today, have subsequently gained specificity and efficiency in 
purifying selection [41]. In this respect, enzymes associated with biosynthesis of natural products 
could be considered “evolutionary intermediates” from the perspective of primary metabolism. 
However, it may be beneficial for enzymes associated with secondary metabolism to stay as 
“generalists” and to never reach the specialization state of their counterparts in primary 
metabolism. In secondary metabolism, negative selection may prevent the evolution of highly 
efficient and specific enzymes, since such a high specialization state could be detrimental for 
increasing chemical diversity [37]. In contrast, promiscuous “generalist” enzymes can play a 
major role in both the acquisition of novel genes by natural product biosynthetic pathways and the 
functional diversification of enzymes already encoded on those pathways
A Pharmaceutical Model for Pathway Evolution
The chemical complexity of secondary metabolites obfuscates both their evolutionary origins and 
the selective pressures driving the diversification of their biosynthetic pathways. The widely 
considered Screening Hypothesis theory by Firn and Jones originating in 1991 is based on the 
proposition that “potent biological activity is a rare property for any one molecule to possess” [45–
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diversity at low cost, similarly to how compound libraries are screened by pharmaceutical 
companies for desired bioactivities [45, 46]. However, the accumulating wealth of genomic data 
and the elucidation of the biosynthetic logic of all major classes of natural products [14, 15, 16] 
warrants a revision to the hypothesis. 
We propose a two-step model that accounts for much of the chemical diversity of microbial 
natural products. The first step in this model is the slow appearance of ancestral biologically active 
metabolites. The first appearance of a new natural product family required the recruitment and 
cooperation of multi-gene combinations resulting in the formation of novel metabolic pathways. 
Spontaneous chemical transformations, side products produced through other enzymatic pathways 
and acquisition of new extracellular substrates may have contributed to the appearance of the first 
secondary metabolites in a manner similar to the evolution of early primary metabolism [48]. This 
first stage may have been a cyclical process that has required several rounds of metabolite-enzyme 
coevolution [48], which has finally resulted in the emergence of bioactive secondary metabolites. 
The relative low number of natural product classes suggests that the evolution and dissemination 
of new natural product classes were rare events (Fig. 1). This scenario is in agreement with current 
data that indicates that only a limited number of enzyme families are responsible for the bulk of 
the structural diversity found in microbial natural products [49]. 
Our model dictates that the majority of natural products have appeared in the second step through 
near endless modulation of pre-existing secondary metabolic pathways. The key difference is that 
the natural products emerging at this later stage have evolved from already existing bioactive 
secondary metabolites. The driving force for the chemical diversification has been the modulation 
of the biological activity due to selective pressures experienced under changing environmental 
conditions. Ancestral secondary metabolites may have displayed low target affinity or weak 
biological activity, but have served as templates to maximize potency through optimization of 
chemical structure. Formally, the second step follows the forward pathway evolution model by 
Granick [48, 50], which states that all pathway intermediates have been, at some stage, the end 
products of the given pathway, but have evolved further to carry out the same function more 
efficiently. In keeping with the pharmaceutical theme, this process would be analogous to Lead 
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structures of natural products may have significant consequences for the biological activity of the 
molecule [1, 2]. 
This two-part model implies that the formation of novel metabolite classes were rare events, but 
were followed by frequent and continuous structural diversification to form large natural product 
families (Fig. 1). In the next sections, we will focus specifically on the second step and provide 
examples how novel natural products can arise through simple evolutionary events. We highlight 
cases where single point mutations, gene duplication, recombination and horizontal gene transfer 
have allowed facile generation of chemical analogs.
Direct Modulation of Enzyme Function in Biosynthetic Gene Clusters
Most evolutionary theories highlight the importance of the gene duplication event in molecular 
evolution [41, 51, 52], since it provides a mechanism for generating novel chemistry while 
retaining the original function [51–53]. However, Ohno’s law of Evolution by Gene Duplication 
[51] would appear not to apply to secondary metabolism. A growing body of evidence suggests 
that natural product gene functions may also evolve directly in the biosynthetic gene clusters 
without gene duplication [54], which is possible because genes involved in secondary metabolism 
are not essential for the survival of the host. This is most apparent in comparisons of related 
secondary metabolite biosynthetic gene clusters, where highly conserved enzymes can nonetheless 
catalyze distinct chemistry. Perhaps the most illustrative examples are found from evolution-
inspired protein engineering experiments, where the activities of functionally distinct enzymes can 
be interchanged with single point mutations [39, 43]. 
Anthracyclines are a family of cytotoxic tetracyclic polyphenolic compounds, which are 
synthesized by type II iterative polyketide synthases (PKS) and modified by a range of tailoring 
enzymes [17]. Many anthracycline biosynthetic gene clusters found in actinomycetes encode 
SAM-dependent methyltransferases (Fig. 2A). These promiscuous enzymes have diversified to 
catalyze 4-O-methylation, 10-decarboxylation or 10-hydroxylation, with additional changes in 
substrate specificity in regards to the glycosylation state [54]. The functional diversification 
appears to have occurred directly in situ within the gene clusters (Fig 2B), as demonstrated by the 
congruence of phylogenetic trees composed of the methyltransferases and core anthracycline 
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methyltransferase [55], but it harbors moonlighting 10-decarboxylation activity towards 
anthracyclines with a free carboxyl group at C10 [39]. In turn, this latter promiscuous activity has 
evolved to 10-hydroxylation functionality as observed in RdmB from the rhodomycin pathway 
[56]. The shift in catalysis could be pinpointed to insertion of a single serine residue S297 to 
DnrK, which resulted in gain of 10-hydroxylation activity [39]. Surprisingly, the inserted serine 
points away from the active site in DnrK-Ser, but since it is located in α16-helix, the insertion 
results in rotation of the preceding phenylalanine F296 towards the active site. The bulky F296 
blocks a water channel to the surface of the protein in a manner similar to native RdmB (Fig. 2C). 
Closure of the active site and protection of a carbanion intermediate (Fig. 2A) from protonation by 
solvent molecules is likely to be crucial for the switch in activity [39]. The third enzyme type 
represented by EamK from the komodoquinone pathway catalyzes 10-decarboxylation solely (Fig. 
2A). Even though the structural basis for 10-decarboxylation is still unresolved, the loss of 
methylation activity could result from misalignment of the substrate in relation to SAM, which 
would leave 10-decarboxylation as the sole functionality for EamK [54]. Interestingly, 10-
hydroxylation may offer the producing organism significant selective advantage, since this 
functionality appears to have evolved independently on at least two occasions as exemplified by 
the CalMB-type proteins (Fig. 2B). 
Angucyclines produced mainly by Streptomyces bacteria are another large group of aromatic 
polyketides that include gaudimycins, urdamycins, jadomycins and landomycins [57]. The various 
end products are formed via complex redox modification cascades and glycosylation from the last 
common intermediate prejadomycin (Fig. 3A) [58]. All pathways include FAD-dependent mono-
oxygenases that are responsible for C12 hydroxylation and quinone formation [33]. However, in 
gaudimycin biosynthesis PgaE catalyses a secondary hydroxylation at C12b [42, 59], whereas the 
homologous flavoenzyme JadH from the jadomycin pathway performs 4a,12b-dehydration [42, 
60]. The emergence of 12b-hydroxylation activity in PgaE could be linked to just two residues P78 
and I79 distal from the active site [61]. These residues reside at the dimerization interface and, 
while the mutations allowed the ancestral protein to gain C12b hydroxylation functionality, lead 
simultaneously to substrate inhibition for the original C12 hydroxylation activity. Urdamycin 
biosynthesis continues from the double hydroxylated intermediate with C6 ketoreduction (Fig. 3B) 
by a short chain alcohol dehydrogenase/ reductase (SDR) UrdMred [62]. LanV from the related 
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hydroxylated pathway intermediate as a substrate and catalyse the ketoreduction with opposite 
stereochemistry [63]. A single point mutation S192 to I192 in LanV, where the longer side-chain 
pushes the substrate into a different angle above NADPH, was sufficient to convert the activity 
towards use of C12,C12b-hydroxylated substrates [62, 63]. The importance of enzyme 
promiscuity in these redox cascades was highlighted under artificial conditions where native JadH 
and LanV were used to catalyze ancestral non-native reactions leading to formation of the non-
cognate urdamycin pathway product [33].
A key difference in landomycin and urdamycin lies in the glycosylation steps (Fig. 3C), where the 
first D-olivose unit is attached either via a canonical O-glycosidic [64] or an atypical C-C bond 
[65, 66], respectively. The LanGT2 has been engineered to catalyze C-glycosylation through 
exchange of just 12 residues in the α3-helix from the UrdGT2 template [67]. The modification led 
to reduction in the size of the aglycone binding pocket in LanGT2 particularly by I58 and I62 [68]. 
Docking studies indicated that subtle repositioning of the aglycone relative to the sugar nucleotide, 
with the C9 atom moving towards the co-substrate and the C8 hydroxyl group away from the co-
substrate, leading to a switch in regiochemistry and even the catalytic mechanism of LanGT2 [68]. 
Natural enzyme promiscuity is also evident in the diversification of terpene natural products [69]. 
The squalene hopane synthase AacSHC from Alicyclobacillus acidocaldarius is able to convert a 
wide range of functionalized long-chain linear polyprenoids [34, 70]. Catalysis is initiated by an 
aspartic acid D376 acting as an unusually strong Brønsted acid leading to C=C bond protonation 
[71]. The hydrophobic binding pocket of the enzyme chaperones the flexible substrates into 
product-like conformations that induce cyclization cascades that may be terminated either by 
releasing water molecules through specific channels or protonation of the terminal isoprene unit 
(Fig. 4A). However, the native enzyme generally does not accept relatively small substrates, in 
contrast to the related enzyme from Zymomonas mobilis [72]. Single point mutations in AscSHC 
were sufficient to the reshape the chiral hydrophobic environment in the active site to alter both 
the substrate and catalytic specificity of the enzyme to diverse compounds [73]. Similarly, six out 
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Enzymes of the 2-oxoglutarate (2OG) and non-heme iron dependent oxygenases are able to 
perform energetically demanding chemical transformations [18, 19] and are common components 
of secondary metabolic pathways [19]. Their functional divergence is particularly prevalent in the 
formation of β-lactams, where the enzymes catalyze various hydroxylation, cyclization, 
desaturation and epimerization reactions [18]. Studies on fungal meroterpenoids (Fig. 4B) have 
illustrated how highly divergent products may be obtained through dynamic skeletal 
rearrangement [43]. AusE [74] and PrhA [75] both utilize preaustinoid A1 as a substrate, but 
whereas the former catalyzes desaturation at C1–C2 and carbocyclic rearrangement to 
preaustinoid A3, the latter first desaturates at C5–C6, followed by rearrangement of the A/B-ring 
to form berkeleydione. The functions of the two proteins could be interchanged by manipulating 
two amino acids in the vicinity of the A-ring [43]. The importance of enzyme promiscuity was 
evident as a single point mutation AusE-S232A was sufficient for gaining a PrhA-type “B-ring 
expansion” activity, while still retaining its natural “spiro-lactone forming” activity. In case of a 
PhrA- V150L-A232S double mutant, the enzyme gained unnatural hydroxylation functionality as 
a third activity, while the addition of a third M241V mutation to this scaffold led to formation of 
even more novel reaction products [43]. 
Gene Duplication Allows Formation of More Complex Chemical Structures
Many natural product biosynthetic gene clusters encode two or more copies of homologous genes 
[12], which have presumably arisen through gene duplication. Gene duplication offers a means to 
build larger and chemically more complex natural products from ancestral pathways. This may 
result in the formation of novel compounds with enhanced or altered biological activity that 
confers a selective advantage on the producing organism. Enzyme promiscuity is likely to play a 
central role in the functional differentiation of duplicated gene products, and examples of both 
substrate and catalytic promiscuity are abundant in natural product biosynthesis [76–78]. The 
process is reminiscent to events in the early evolution of ancestral core metabolism, where Ycas 
[79] and Jensen [80] proposed independently that broad-specificity generalist enzymes originally 
participated in multiple pathways, but duplication and divergence to specialist enzymes allowed 
for the foundation of primary metabolic pathways [48].   
Examples of catalytic promiscuity are found in many pathways where individual standalone genes 
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dually linked aminosugar connected at C1 and C2 through both O- and C-glycosylation, 
respectively [81]. Gene duplication and catalytic promiscuity have been important in the evolution 
of the unique substructure. This chemistry originates from an unusual two-component mono-
oxygenase system that is responsible for the installation of the C1 hydroxyl group [82, 83]. The 
system is composed of an SDR-enzyme, SnoaW, and a protein SnoaL2 homologous to canonical 
polyketide cyclases such as SnoaL [82]. In a manner similar to flavin chemistry, NADPH-
dependent reduction of the anthracycline quinone by SnoaW allows the substrate to react with 
molecular oxygen to form a peroxide intermediate, which is converted to the hydroxylated 
reaction product by SnoaL2. The canonical reaction of the anthracycline fourth ring polyketide 
cyclases such as SnoaL [84] and AknH [85] is to catalyze aldol condensations that determine the 
stereochemical configuration at C9, but interestingly SnoaL2 has also been observed to harbor 
minor ancestral cyclization activity [76]. After attachment of L-rhodosamine by the 
glycosyltransferase SnogD [81, 86, 87], the subtype epitomizing C2–C5´´ bond is formed by the 
2OG and non-heme iron dependent oxygenase SnoK [78]. However, a gene duplication event has 
led to the appearance of C4´´ epimerase SnoN from SnoK [78]. Despite drastic differences in the 
chemistries catalyzed by the two enzymes, both proteins are able to use the same substrate and the 
key difference in catalysis appears to be whether the C4´´ or C5´´ carbon is positioned in front of 
the high valent Fe=O center [78].
The biosynthesis of the fungal novofumigatonin monoterpenoid offers another fascinating 
example of gene duplication within a single biosynthetic pathway [77]. The novofumigatonin 
biosynthetic gene cluster encodes three copies of 2OG and non-heme iron-dependent enzymes 
responsible for endoperoxide formation and rearrangement (Fig. 5B). The endoperoxide forming 
NvfI utilizes asnovolin as a substrate and is responsible for the incorporation of three oxygen 
atoms [77]. The mechanistic proposal follows classical hydroxylation chemistry that is initiated by 
hydrogen abstraction, but with an unusual additional incorporation of molecular oxygen prior to 
completion of the reaction cascade through oxygen rebound. The second enzyme, NvfE, 
catalyzing orthoesterification has lost the ability to utilize 2OG as a co-substrate, but requires the 
non-heme iron for initial cleavage of the endoperoxide and subsequent rearrangements [77]. 
Finally, NvfF is engaged in two consecutive oxidative desaturation and hydroxylation reactions, 
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Recombination and Substrate Promiscuity Allow Diversification of Modular Biosynthetic 
Systems
Polyketides and non-ribosomal peptides belong to two of the most important, structurally diverse 
and widespread natural product classes in nature. Type I polyketides and non-ribosomal peptides 
are synthesized on modular enzyme complexes that act as assembly lines [14,15]. Nonribosomal 
peptide synthetase (NRPS) and PKS biosynthetic pathway have been discovered from all three 
domains of life [24], and the thiotemplate based biosynthetic logic underpinning their biosynthesis 
has been elucidated in detail [14, 15]. Briefly, these module systems are comprised of loading and 
elongation modules responsible for the initiation of biosynthesis and the growth of the 
polyketide/peptide intermediate [14, 15]. The elongation modules of type I polyketides requires 
three essential domains (Fig. 6A); the polyketide chain is tethered to the acyl carrier protein 
(ACP), while the acyltransferase (AT) selects the extended units to be incorporated by the 
ketosynthase (KS) domain [14]. The β-keto functional group may be reduced in a sequential 
manner by auxiliary ketoreductase- (KR), dehydratase- (DH) and enoylreductase- (ER) domains to 
generate structural diversity [14]. The essential domains in NRPS elongation modules (Fig. 6A) 
include the adenylation (A) domain for selection and activation of a range of proteinogenic and 
non-proteinogenic amino acids, the condensation (C) domain for peptide bond formation and the 
peptidyl carrier protein (PCP) domain, to which the nascent peptide intermediate is bound as a 
thioester [15]. In both of these systems, elongation modules are responsible for the growth of the 
polyketide or peptide intermediates, which are passed from one ACP/PCP domain to another until 
the biosynthesis is typically terminated in the final module by thioesterase (TE) domain [14,15]. A 
range of additional optional domains increase the structural diversity of the final polyketide and 
non-ribosomal peptide end-product [14,15]. The modular architecture of NRPS and PKS enzymes 
coupled with high sequence similarity promotes recombination events between modules. This 
recombination process can result in the loss, gain or replacement of modules, as well as specific 
domains within a module, resulting in reprogramming of the chemical diversity encoded by the 
pathway. 
Microcystins (Fig. 6A) are potent inhibitors of eukaryotic protein phosphatases 1 and 2 A that are 
responsible for infrequent animal toxicosis around the world [8, 88]. These hepatotoxins are one of 
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Microcystins are the end-products of mixed NRPS-PKS enzyme complexes encoded in a 55-kb 
microcystin (mcy) gene cluster [8]. Recurrent homologous recombination between McyB1 and 
McyC modules resulted in the replacement of the substrate conferring portions of the A domains 
leading to the incorporation of a range of amino acids at the variable X and Z positions of the 
toxin [8, 90]. In some cases, the substrate conferring portions of the A domains in the resultant 
McyB1 and McyC are identical, but nevertheless incorporate different amino acids [90]. This 
phenomenon was hypothesized to be the result of a conflict between the substrate specificities of 
the gatekeeping C domain and the recombinant A domain [90]. Experimental work to recapitulate 
entire McyB1 and McyC modules using artificial combinations of domains confirmed this 
hypothesis and demonstrated that the structural diversity observed could be best explained by a 
series of point mutations and homologous recombination events [91]. A larger recombination 
event resulting in the fusion of the McyA2 and McyB2 modules concomitant with deletion of 
McyB1 module and a change in the substrate specificity of the McyA1 module from L-Ser to L-
Tyr is thought to have resulted in the creation of nodularin biosynthetic pathway from an ancestral 
microcystin synthetase pathway [8].
Few studies report the redesign of modular PKS natural product biosynthetic pathways using 
natural recombination. Pikromycin and erythromycin are related macrolide antibiotics produced 
by Streptomyces bacteria (Fig. 6B). Homologous recombination in yeast was utilized to generate 
hybrid pikromycin genes either with artificial combinations of two pikromycin modules or 
recombination with a module from the erythromycin pathway [92]. Recombination occurred 
within the KS or AT domains in the majority of cases with in-frame recombination frequencies of 
90% [92]. Many of the chimeras led to formation of soluble proteins and expected modified 
macrolactones were synthesized with high efficiency [92]. A similar approach resulted in the 
successful engineering of the rapamycin (Fig. 6C), a type I polyketide macrolide with 
immunosuppressive and anti-proliferative properties, biosynthetic pathway [93]. Serendipitous 
natural recombination events were used directly to generate a library of novel analogs in a 
rapamycin-producing Streptomyces strain [93]. A temperature sensitive plasmid was first 
integrated into the gene cluster using homologous recombination. Surprisingly, activation of the 
temperature sensitive replicon, while still integrated into the genome, led to the production of 
twenty chemical variants of rapamycin [93]. Genome sequencing revealed that the progeny 
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generated at positions of high sequence similarity [93]. The biological activity of the novel 
truncated analogs were modulated, which is in agreement with our two-step model. Rapamycin 
harbors peptidyl-prolyl isomerase (PPIase) inhibitory activity and is able to modulate the activity 
of the mTORC1 pathway [94, 95]. One of the rapamycin chemical variants (Fig. 6C) retained high 
PPIase inhibitory activity, but displayed 100-fold reduced activity against p-S6 formation in the 
mTORC1 pathway [93]. 
Recent evolution-guided protein engineering approaches that mimic natural recombination events 
have been utilized in rewiring natural product biosynthetic pathways. Aureothin and neoaureothin 
(Fig. 6D) are antifungal metabolites produced on related modular PKS enzyme complexes by 
Streptomyces spp. [96]. The neoaureothin (nor) assembly line contains two additional modules in 
comparison to the aureothin (aur) gene cluster suggesting the two pathways are related through the 
gain or loss of modules due to recombination events [97]. Engineering experiments to insert 
modules into the aur pathway or deleting the modules from the nor PKS resulted in the expected 
end-products of the hybrid pathways [97]. The antifungal activity is dependent on the presence of 
the tetrahydrofuran ring system, which is formed during tailoring steps of the biosynthesis by the 
oxygenases AurH and NorH [97]. Only AurH was able to utilize both aureothin and neoaureothin 
as substrates, suggesting that the aureothin pathway may be the ancestral pathway [97]. 
Antimycins (Fig. 6E) are a family of di-lactone depsipeptides with anti-fungal, anti-cancer, and 
anti-inflammatory bioactivities [98]. Homologous recombination inspired protein engineering 
experiments allowed the successful reprogramming of the antimycin biosynthetic pathway by 
expanding and contracting the modular architecture using three related hybrid NRPS-PKS 
pathways encoding antimycin, JBIR-06 and neoantimycin (Fig. 6E) as templates [98]. 
Horizontal Gene Transfer Facilitates the Distribution of Natural Product Biosynthesis 
Enzymes
Horizontal gene transfer is thought to play a central role in the diversification of natural product 
biosynthetic pathways [12, 99]. It is well established that entire biosynthetic gene clusters can 
spread through horizontal gene transfer where they confer a selective advantage upon the recipient 
organism [12, 20, 99]. The spread of natural product pathways is facilitated by the organization of 
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plasmids [20, 99, 100]. The limited host range of genetic elements like conjugal plasmids or 
pathogenicity islands as well as codon usage, the availability of metabolic precursors, or 
differences in transcription and regulation place restrictions on horizontal gene cluster transfer 
making the spread of natural product biosynthetic pathways more common amongst closely 
related organisms [12, 20, 99]. However, horizontal gene transfers are necessary to explain the 
production of identical secondary metabolites by microbes belonging to different phyla, for 
example the lyngbyatoxin biosynthetic pathway is found in both the actinobacteria and 
cyanobacteria phyla [101], while the macrolide scytophycin is found in both the proteobacteria 
and cyanobacteria phyla [102]. The same natural product can also be shared between organisms 
from different domains, for example the UV-sunscreen mycosporine is produced by a range of 
photosynthetic algae and bacteria [7], the beta-lactam antibiotic penicillins and cephalosporins are 
produced by fungi and bacteria [103] and potent neurotoxic saxitoxins [104] are produced by both 
cyanobacteria and dinoflagellates. 
In addition to transfer of entire gene clusters, natural product biosynthetic pathways also evolve 
through the acquisition of new individual enzymes by horizontal gene transfer, which leads to the 
diversification of natural product chemical structures [12, 99]. The O-acetylation of the 
cyanobacterial microcystin toxin is the result of a gain of an acetyltransferase by strains of the 
cosmopolitan genus Nostoc [105] concomitant with the loss of a SAM dependent O-
methyltransferase found in all other microcystin biosynthetic pathways [8]. This enzyme belongs 
to the XAT class of hexapeptide acyltransferases that catalyze the CoA-dependent acetylation of a 
variety of hydroxyl-bearing acceptors including chloramphenicol and streptogramin antibiotics 
[105, 106]. Since these enzymes confer resistance to antibiotics through covalent modifications, 
they are widely found in microbes due to the spread of antibiotic resistance genes [106, 107]. 
Members of the xenobiotic acetyltransferase family exhibit some degree of substrate promiscuity 
[105–109], which may promote the incorporation of this enzyme into non-cognate natural product 
biosynthetic pathways. The gain of natural product biosynthetic enzymes in this manner would 
obviate the need for gene duplication or point mutations affecting the activity of pre-existing 
enzymes.
The ABBA superfamily of prenyltransferases (Fig. 7) catalyze the aromatic prenylation of an 
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low primary sequence similarity and are instead defined by a conserved tertiary architecture 
consisting of a ring of solvent-exposed α-helices surrounding a central barrel of ten antiparallel β-
strands [111, 112, 114]. They catalyze the prenylation of aromatic substrates by electrophilic 
aromatic substitution similar to Friedel-Crafts alkylation [113]. ABBA prenyltransferases catalyze 
the transfer of C5, C10, or C15 prenyl groups derived from the corresponding isoprenyl 
diphosphate metabolites onto a variety of electron-rich aromatic acceptors [112]. Characterized 
ABBA prenyltransferases typically exhibit strict specificity for their prenyl donors, but can accept 
diverse aromatic acceptors [115]. ABBA prenyltransferases commonly exhibit substrate 
promiscuity and typically work on a variety aromatic acceptors [111, 113, 115, 116]. For example, 
representative members of the indole alkaloid ABBA prenyltransferase family catalyze the 
regioselective normal or reverse prenylation of a variety of natural products [114, 117–120]. The 
KgpF, SirD, an PagF prenyltransferases from the  kawaguchipeptin, sirodesmin PL, and 
prenylagaramide biosynthetic pathways, respectively, have all demonstrated substrate promiscuity 
in vitro [121–123]. Such broad substrate specificity could be expected to facilitate the spread and 
integration of these enzymes into new natural product biosynthetic pathways. Interestingly, the 
permissive prenyltransferases PriB, FgaPT2 and CdpNPT were all shown to catalyze the 
prenylation of daptomycin [121], an unrelated macrocyclic lipopeptide antibiotic in clinical use 
(Fig. 7). Prenylation of daptomycin using these enzymes improved the antibacterial activity of this 
bactericidal antibiotic [121]. ABBA prenyltransferases are found in a wide variety of natural 
product classes including indole alkaloids, peptides, flavonoids, coumarins, terpenoids, and 
phenazines [110–114, 124]. Indeed phylogenetic analysis suggests the active exchange of ABBA 
prenyltransferases between different natural product classes results in increased structural diversity 
of the natural products they encode [125]. 
Novel natural product enzymes are often thought to be recruited from primary metabolism [126]. 
However, the origin of natural product biosynthetic enzymes has not been widely studied and 
many could originate from other natural product pathways in addition to primary metabolism. 
Substrate promiscuity and the ability to act on non-cognate substrates should facilitate the 
dissemination and integration of natural product biosynthetic enzymes into novel natural product 
biosynthetic pathways through horizontal gene transfer. Natural product biosynthesis is 
traditionally viewed as a constrained self-contained process with all of the enzymes necessary for 
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biosynthesis of erythrochelin requires crosstalk between two separate non-ribosomal peptide 
synthetase biosynthetic gene clusters [128]. Here the authors demonstrate that a delta-N-
acetyltransferase enzyme located in separate non-functional non-ribosomal peptide synthetase 
biosynthetic gene cluster was necessary for the biosynthesis of erythrochelin [128]. Similarly, 
hybrid peptides produced through the use of non-proteinogenic amino acids encoded in unrelated 
biosynthetic pathways are commonly reported in cyanobacteria [129, 130]. The formation of 
natural products that are intermediates between two pathways could be seen as a step towards full 
integration of novel biosynthetic genes into natural product pathways. Overall, it is clear that 
substrate and catalytic promiscuity is commonly exhibited by enzymes encoded in many natural 
product pathways [32–36]. However, the implications of this promiscuity for the spread and 
integration of natural product enzymes into new natural product pathways are not yet widely 
considered.
Conclusions and future perspectives
Here we present a two-step evolutionary model to explain how much of the chemical diversity of 
microbial natural products has arisen. The fact that only a handful of enzymatic machineries are 
responsible for much of the observed chemical diversity reinforces the challenges in the de novo 
evolution of new natural product metabolic pathways. We propose that the rate-limiting step has 
been the original appearance of bioactive molecules, which requires sets of enzymes from primary 
metabolism to act in a concerted manner to build novel natural product biosynthetic pathways. It is 
interesting to note that the distribution of natural product biosynthetic pathways in living 
organisms is typically patchy with polyketide, terpene and peptidic natural product biosynthetic 
gene clusters being widely distributed and common in diverse bacterial phyla [13–16, 23]. 
However, other secondary metabolites are found from a much narrower range of organisms. For 
example, recent work indicates that the relatively rare C-nucleoside metabolites are the result of 
convergent evolution that are synthesized using three distinct biosynthetic logic in actinobacteria 
[131–133]. An interesting question from an evolutionary perspective is whether these rare 
metabolites may have come into existence only at a later stage of evolution and have not had the 
time for diversification and dissemination, or whether the enzymes residing in these pathways are 
not as suitable for functional diversification as those found on the more commonly distributed 
pathways. Nonetheless, this provides reassurances that new natural product families with novel 
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Our model predicts that the explosion in the numbers of natural products has occurred at a later 
stage in a process where pre-existing scaffolds and gene clusters are modified to alter the 
biological activities. We highlight with examples that in many cases single evolutionary events, 
such as point mutations, recombination or horizontal gene transfer, have been sufficient to convert 
catalytic activities towards novel chemistry. In particular, recombination and horizontal gene 
transfer events have been shown to lead to the production of novel secondary metabolite libraries 
that harbor modulated biological activities [93, 121. It has also become apparent that gene 
duplication events are not essential to the diversification of natural product biosynthetic pathways. 
Instead gene duplication facilitates the functional diversification of gene products in situ, and that 
the major role of gene duplication is to allow formation of more complex chemical structures. 
Enzyme promiscuity is important in understanding how natural product biosynthetic gene clusters 
diversify and gain new functions. Both substrate and catalytic promiscuity play key roles in the 
diversification of natural products by promoting the incorporation of horizontally transferred 
genes into secondary metabolic pathways, but also for the functional differentiation of natural 
product enzymes to catalyze novel chemistry. This intrinsic property of natural product enzymes 
can be exploited in biotechnology, but offers challenges for the rational design of new pathways. 
Nonetheless, the pervasive substrate promiscuous activities of natural product enzymes provide a 
major advantage for synthetic biology efforts to construct novel natural product pathways. A better 
understanding of how natural product biosynthetic pathways evolve should provide a source of 
inspiration for the rational design and reprogramming of biosynthetic pathways in order to 
produce new natural product analogs. 
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Figure legends
Figure 1. A Pharmaceutical model for evolution of secondary metabolites. Inner ring, the majority 
of natural products are derived from primary metabolites such as malonyl-CoA, amino acids and 
glucose-1-phosphate. Middle ring, the Screening Hypothesis represents the emergence of the 
various classes of biologically active natural products. This requires the organization of gene 
collectives to form novel biosynthetic pathways and has therefore occurred slowly. Outer ring, the 
Lead Optimization Hypothesis dictates that once a bioactive compound has arisen, chemical 
derivatives to produce compound families can evolve quickly. Novel metabolites have appeared in 
some instances through single evolutionary events such as point mutations, recombination or 
horizontal gene transfer. 
Figure 2. Evolution of enzyme function without gene duplication in the biosynthesis of 
anthracycline SAM-dependent methyltransferases. (A) The 4-O-methyltransferase DnrK harbors 
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carboxylation reaction has allowed development of novel chemistry through substrate-activated 
reaction with molecular oxygen leading to 10-hydroxylation by RdmB. The loss of 4-O-
methylation functionality has left 10-decarboxylation the sole enzymatic activity of EamK. 
Legend: R1= -OH or l-rhodosamine or l-rhodosamine-2-deoxyfucose-cinerulose. R2 = thiol 
reducing agent such as glutathione. (B) Phylogenetic trees demonstrating the co-evolution of the 
methyltransferases (left) with proteins involved in formation of the common core anthracycline 
scaffold (right). The evolution of anthracyclines is represented by concatenated sequences of 
ketosynthase α-subunits, 9-ketoreductases, first ring aromatases, and 15-methyl esterases. (C) 
Close-up views of the active sites of DnrK, DnrK-Ser and RdmB. DnrK contains a channel to the 
surface of the protein lined by Q295 that enables water molecules to protonate the carbanion 
intermediate. In contrast, this channel is blocked by F296 in DnrK-Ser and by F300 in RdmB. 
Protein structures were visualized using PyMol (version 0.99).
Figure 3. Enzyme promiscuity and the diversification of angucycline biosynthetic pathways. (A) 
The multifunctional flavoenzymes JadH, PgaE and LanE all use prejadomycin as a substrate, but 
catalyze distinct chemistry. In PgaE, the ability to catalyze 12b-hydroxylation has emerged 
through mutations at the dimerization interface at P78 and I79, which has resulted in appearance 
of substrate inhibition in the 12-hydroxylation reaction. (B) A single point mutation in the 6-
ketoreductases LanV was sufficient to convert 30% of the enzymatic activity towards UrdMred-
type chemistry. (C) Modification of the 3-helix in the glycosyltransferase LanG according to the 
UrdGT2 template repositions I58 and I62 towards the active site, leading to the conversion of an 
O-gycosyltransferase into a C-glycosyltransferase. Protein structures were visualized using PyMol 
(version 0.99).
Figure 4. Evolution and rearrangement of terpenoid scaffolds. (A) The hydrophobic binding 
pockets of squalene hopane cyclases such as AacSHC are able to fold polyprenoids resulting in 
distinct outcomes. Single point mutations (e.g. F385C, G600F or Y420W) have been shown to be 
sufficient to alter substrate specificities and cyclization patterns. (B) The non-heme iron and 2OG 
dependent AusE and PrhA catalyze distinct skeletal rearrangement reactions of meroterpenoids. A 
few point mutations, influencing positioning of the A-ring in front of the high-valent iron-oxo 
center, are sufficient to both interconvert the enzymatic activities and for novel chemistry to 
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nature of the substrates and (B) the potency of the catalytic machineries of the enzymes. Protein 
structures were visualized using PyMol (version 0.99).
Figure 5. Evolution of complex chemical structures through gene duplication and functional 
diversification. (A) The biosynthetic pathways of anthracycline antibiotics nogalamycin and 
aclacinomycin contain conserved fourth ring cyclases SnoaL and AknH, respectively. An atypical 
two-component mono-oxygenase system has emerged after gene duplication and recruitment of 
the cyclase-like SnoaL2 and AclR to function together with the quinone reductases SnoaW and 
AclQ, respectively. In nogalamycin biosynthesis, another gene duplication event has occurred at a 
later stage, which has led to conversion of the non-heme iron and 2OG dependent carbocyclase 
SnoK into the epimerase SnoN. (B) Three functionally distinct proteins belonging to the non-heme 
iron and 2OG dependent enzyme family, NvFI, NvfE and NVfF, are involved in complex 
oxidative rearrangement processes in the biosynthesis of novofumigatonin. In contrast to other 
members of the family, NvfE does not utilize 2OG as a cosubstrate and relies solely on the non-
heme iron for the orthoesterification reaction. Protein structures were visualized using PyMol 
(version 0.99).
Figure 6. Biosynthesis of natural products through modular assembly lines allows the emergence 
of novel metabolites by homologous recombination. (A) The biosynthetic logic for microcystin 
formation. A series of recombination events leading to replacement of the A domains of the 
McyB1 and McyC modules in different strains of cyanobacteria is responsible for the bulk of the 
observed chemical variation in the microcystin family of hepatotoxins. Chemical structures of 
closely related secondary metabolites (B) pikromycin and erythromycin, (C) rapamycin and a 
novel analog with altered biological activity, (D) aureothin and neoaureothin, and (E) antimycin 
and JBIR-06. R1 and R2 various alkyl groups. Abbreviations: acyl carrier protein (●), 
ketoreductase domain (KR), C-methyltransferase domain (CM), dehydratase domain (DH), 
acyltransferase domain (AT), ketosynthase domain (KS), aminotransferase domain (AMT), 
adenylation domain (A), N-methyltransferase domain (M), codensation domain (C) peptidyl 
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Figure 7. Enzyme promiscuity and gain of new functionality in natural product biosynthetic gene 
clusters. (A-B) ABBA prenyltransferases catalyze the isoprenylation of a variety of aromatic 
natural products and can be divided into a number of families widely distributed in natural product 
biosynthetic gene clusters of a variety of bacteria and fungi (C) ABBA prenyltransferases display 
a distinctively barrel shape fold (e.g. PriB and FgaPT2), where the substrate binding site is lined 
with β-sheets. Daptomycin is a non-ribosomal peptide antibiotic that can be prenylated by the 
unrelated permissive PriB and FgaPT2 enzymes in vitro. Protein structures were visualized using 
PyMol (version 0.99).
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